PT Soho Global Health Tbk, together with its subsidiaires, operates as a healthcare company in Indonesia. It operates through Distribution, Professional Product, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonprescription brand products to treat and prevent diseases; and provides contract manufacturing services for various dosage forms, as well as distribution and logistics services. It also offers body defense, stamina and vitality, brain nutrient, eye health, skin care, weight management, and wellness products; sells and markets medical devices and medical equipment products in the areas of wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics; and provides product registration, marketing intelligence, sales, and marketing support services. PT Soho Global Health Tbk was founded in 1946 and is headquartered in Jakarta, Indonesia.
Indonesian Market Performance
7D7 Days: -2.0%
3M3 Months: 9.5%
1Y1 Year: 7.9%
YTDYear to Date: 6.1%
Over the last 7 days, the market has dropped 2.0%, driven by a pullback of 3.8% in the Financials sector. Meanwhile, the Communication Services sector has outperformed, gaining 4.1% in that time. In the last year, the market is actually up 7.9%. Earnings are forecast to grow by 7.4% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.